Direct in vivo reprogramming to relieve tissue ischemia via induced vasculogenesis
There is an ongoing need for innovative cell and regenerative medicine therapies to promote vascular repair and regeneration to meet the growing global health concern of ischemic cardiovascular diseases. Direct reprogramming of somatic cells into an induced pluripotent state caused scientists to rec...
Gespeichert in:
| Veröffentlicht in: | Molecular therapy Jg. 33; H. 11; S. 5338 |
|---|---|
| Hauptverfasser: | , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
05.11.2025
|
| Schlagworte: | |
| ISSN: | 1525-0024, 1525-0024 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | There is an ongoing need for innovative cell and regenerative medicine therapies to promote vascular repair and regeneration to meet the growing global health concern of ischemic cardiovascular diseases. Direct reprogramming of somatic cells into an induced pluripotent state caused scientists to reconsider prior theories of cell differentiation and develop approaches to directly reprogram cells in vivo into other states or fates to adaptively replace cells lost to aging or disease. While direct in vivo reprogramming of fibroblast to cardiomyocytes, neurons, or pancreatic beta islet cell states has been studied since 2008, direct in vivo reprogramming of fibroblasts into induced vasculogenic cells was not reported until 2017. This review provides a brief overview of the field of in vitro direct reprogramming of fibroblasts into induced endothelial cells over the past decade and identifies key similarities and differences in approaches. The primary focus of this review is to discuss in detail 4 published reports of direct in vivo reprogramming of fibroblasts into vasculogenic cell states and identify a series of questions for future studies that will clarify the reprogrammed cells and potential for using these approaches for translation into larger preclinical models or human subjects. |
|---|---|
| AbstractList | There is an ongoing need for innovative cell and regenerative medicine therapies to promote vascular repair and regeneration to meet the growing global health concern of ischemic cardiovascular diseases. Direct reprogramming of somatic cells into an induced pluripotent state caused scientists to reconsider prior theories of cell differentiation and develop approaches to directly reprogram cells in vivo into other states or fates to adaptively replace cells lost to aging or disease. While direct in vivo reprogramming of fibroblast to cardiomyocytes, neurons, or pancreatic beta islet cell states has been studied since 2008, direct in vivo reprogramming of fibroblasts into induced vasculogenic cells was not reported until 2017. This review provides a brief overview of the field of in vitro direct reprogramming of fibroblasts into induced endothelial cells over the past decade and identifies key similarities and differences in approaches. The primary focus of this review is to discuss in detail 4 published reports of direct in vivo reprogramming of fibroblasts into vasculogenic cell states and identify a series of questions for future studies that will clarify the reprogrammed cells and potential for using these approaches for translation into larger preclinical models or human subjects. There is an ongoing need for innovative cell and regenerative medicine therapies to promote vascular repair and regeneration to meet the growing global health concern of ischemic cardiovascular diseases. Direct reprogramming of somatic cells into an induced pluripotent state caused scientists to reconsider prior theories of cell differentiation and develop approaches to directly reprogram cells in vivo into other states or fates to adaptively replace cells lost to aging or disease. While direct in vivo reprogramming of fibroblast to cardiomyocytes, neurons, or pancreatic beta islet cell states has been studied since 2008, direct in vivo reprogramming of fibroblasts into induced vasculogenic cells was not reported until 2017. This review provides a brief overview of the field of in vitro direct reprogramming of fibroblasts into induced endothelial cells over the past decade and identifies key similarities and differences in approaches. The primary focus of this review is to discuss in detail 4 published reports of direct in vivo reprogramming of fibroblasts into vasculogenic cell states and identify a series of questions for future studies that will clarify the reprogrammed cells and potential for using these approaches for translation into larger preclinical models or human subjects.There is an ongoing need for innovative cell and regenerative medicine therapies to promote vascular repair and regeneration to meet the growing global health concern of ischemic cardiovascular diseases. Direct reprogramming of somatic cells into an induced pluripotent state caused scientists to reconsider prior theories of cell differentiation and develop approaches to directly reprogram cells in vivo into other states or fates to adaptively replace cells lost to aging or disease. While direct in vivo reprogramming of fibroblast to cardiomyocytes, neurons, or pancreatic beta islet cell states has been studied since 2008, direct in vivo reprogramming of fibroblasts into induced vasculogenic cells was not reported until 2017. This review provides a brief overview of the field of in vitro direct reprogramming of fibroblasts into induced endothelial cells over the past decade and identifies key similarities and differences in approaches. The primary focus of this review is to discuss in detail 4 published reports of direct in vivo reprogramming of fibroblasts into vasculogenic cell states and identify a series of questions for future studies that will clarify the reprogrammed cells and potential for using these approaches for translation into larger preclinical models or human subjects. |
| Author | Sen, Chandan K Yoder, Mervin C |
| Author_xml | – sequence: 1 givenname: Mervin C surname: Yoder fullname: Yoder, Mervin C organization: McGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA – sequence: 2 givenname: Chandan K surname: Sen fullname: Sen, Chandan K email: c.k.sen@pitt.edu organization: McGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: c.k.sen@pitt.edu |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40785184$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkFtLxDAQhYOsuBf9BYL00ZfWJM2leZT1CguC6HNJ08lulqZdm7aw_96IK_gyZxi-M5yZJZq1XQsIXROcEUzE3T47-mEHGcWUZ7jIMMnP0IJwylOMKZv96-doGcIeY0K4EhdozrAsOCnYAr0_uB7MkLg2mdzUJT0c-m7ba-9du02Gn0HjYIJkcCGMkLhgduCdjrSOpno0UCeTDmZsui20EFy4ROdWNwGuTrpCn0-PH-uXdPP2_Lq-36SGUjGkyirJJK0xtUooEFKDqAhTdV5JZQ03vCBaAqtirS0WQHMrbU5A2yreROkK3f7ujYm_RghD6WM6aBrdQjeGMqd5wajCgkX05oSOlYe6PPTO6_5Y_v2BfgPw3WPA |
| ContentType | Journal Article |
| Copyright | Copyright © 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.ymthe.2025.08.013 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1525-0024 |
| ExternalDocumentID | 40785184 |
| Genre | Journal Article Review |
| GroupedDBID | --- 0R~ 123 29M 36B 39C 4.4 53G AAEDW AALRI AAMRU AAVLU AAXUO AAYWO ABDGV ABJNI ABMAC ABUDA ACGFO ACGFS ACPRK ADBBV ADFRT AENEX AFTJW AGAYW AHMBA AITUG AKAPO AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP ASPBG AVWKF AZFZN BAWUL CGR CS3 CUY CVF DU5 E3Z EBS ECM EFKBS EIF F5P FDB FEDTE FRP HVGLF HZ~ JIG KQ8 M7P NPM O9- OK1 P2P RNTTT RPM SEW SSZ TR2 W2D 7X8 LG5 M41 |
| ID | FETCH-LOGICAL-c226t-9f97472d02f969e67ae6b149d3b79fc5c581a7e4b1a7df06e23f7f31eafb00222 |
| IEDL.DBID | 7X8 |
| ISSN | 1525-0024 |
| IngestDate | Sat Nov 01 15:03:29 EDT 2025 Sun Nov 23 01:41:20 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | in vivo reprogramming wound vasculogenic fibroblast regenerative medicine tissue nanotransfection |
| Language | English |
| License | Copyright © 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c226t-9f97472d02f969e67ae6b149d3b79fc5c581a7e4b1a7df06e23f7f31eafb00222 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 40785184 |
| PQID | 3238429064 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3238429064 pubmed_primary_40785184 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-11-05 |
| PublicationDateYYYYMMDD | 2025-11-05 |
| PublicationDate_xml | – month: 11 year: 2025 text: 2025-11-05 day: 05 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Molecular therapy |
| PublicationTitleAlternate | Mol Ther |
| PublicationYear | 2025 |
| SSID | ssj0011596 |
| Score | 2.4815066 |
| SecondaryResourceType | review_article |
| Snippet | There is an ongoing need for innovative cell and regenerative medicine therapies to promote vascular repair and regeneration to meet the growing global health... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 5338 |
| SubjectTerms | Animals Cell Differentiation Cellular Reprogramming Endothelial Cells - cytology Endothelial Cells - metabolism Fibroblasts - cytology Fibroblasts - metabolism Humans Induced Pluripotent Stem Cells - cytology Induced Pluripotent Stem Cells - metabolism Ischemia - metabolism Ischemia - therapy Neovascularization, Physiologic Regenerative Medicine - methods |
| Title | Direct in vivo reprogramming to relieve tissue ischemia via induced vasculogenesis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40785184 https://www.proquest.com/docview/3238429064 |
| Volume | 33 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB7UVfHiY32_iOA12KZN0p5ExMWDuyyisLeSbRLpYdvVXQv7752kXfYkCF5yKAmUyWTm-zKTGYDbhGmFrMviDpiAxjKxdMyUoBpJDzdoAJXxD4Vf5GCQjEbpsL1wm7VplUub6A21rnJ3R34XoW-JXW3y-H76SV3XKBddbVtorEMnQijjtFqOVlEEdNX-dRFnnDpntKw65PO7FhNEWEgQGfc1PF1_g98wpvc1vb3__uU-7LYokzw0anEAa6bswlbTd3LRhe1-G1E_hNfG5pGiJHVRV8QVufQZWxP0aWTuPiBKrQ2Z-x0iBbJhMykUzla4SKNmaNKks1Yfzm4WsyN47z29PT7Tts8CzRF8zWlqHalgOmA2FakRUhkxRuako7FMbc5znoRKmniMo7aBMCyy0kahUdZjAHYMG2VVmlMgAs1DpGOThDhfB0IJHloRJK4KPVeSncHNUm4Z6rELTqjSVN-zbCW5MzhphJ9Nm4IbmYs1cqSi539YfQE7bk_9c0F-CR2Lp9hcwWZeo5y-rr2C4DgY9n8AzWDE6g |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Direct+in+vivo+reprogramming+to+relieve+tissue+ischemia+via+induced+vasculogenesis&rft.jtitle=Molecular+therapy&rft.au=Yoder%2C+Mervin+C&rft.au=Sen%2C+Chandan+K&rft.date=2025-11-05&rft.issn=1525-0024&rft.eissn=1525-0024&rft_id=info:doi/10.1016%2Fj.ymthe.2025.08.013&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1525-0024&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1525-0024&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1525-0024&client=summon |